# VentrAssistTM LVAD for the Treatment of Advanced Heart Failure - Destination Therapy

> **NCT00490321** · PHASE3 · UNKNOWN · sponsor: **Ventracor** · enrollment: 225 (estimated)

## Conditions studied

- End-stage Heart Failure
- Cardiomyopathies

## Interventions

- **DEVICE:** VentrAssistTM Left Ventricular Assist Device

## Key facts

- **NCT ID:** NCT00490321
- **Lead sponsor:** Ventracor
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-06
- **Primary completion:** —
- **Final completion:** 2012-06
- **Target enrollment:** 225 (ESTIMATED)
- **Last updated:** 2009-09-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00490321

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00490321, "VentrAssistTM LVAD for the Treatment of Advanced Heart Failure - Destination Therapy". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT00490321. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*